Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$357,703
-$4,425,689 QoQ
Shares Held
43,045
-92.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 198 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ARVN ranks #94 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in ARVN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $357,703 | 43,045 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $4,783,392 | 561,431 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,519,804 | 885,843 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,195,209 | 455,158 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,577,437 | 656,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,763,477 | 355,805 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,328,212 | 237,724 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,603,684 | 281,097 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,119,926 | 245,868 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,256,842 | 63,994 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,633,156 | 65,800 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $437,545 | 12,790 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $685,146 | 15,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $214,659 | 5,100 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $229,992 | 2,800 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $543,374 | 6,612 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,262,800 | 16,400 | Shares | Sole | 2021-11-16 | |
| 2020-12-31 | $2,089,278 | 24,600 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $585,315 | 24,791 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $214,957 | 6,409 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||